CIK 0001604821
- Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010894487
- Phone
- +1 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-23 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,523 | $91.38 | $139K | 73,039 |
| 2024-04-22 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion 10b5-1 | +1,250 | 74,562 | ||
| 2024-04-22 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −1,250 | 7,500 | ||
| 2024-04-21 | Sheena Jonathan Director | Exercise or conversion 10b5-1 | +143 | 321,364 | ||
| 2024-04-21 | Sheena Jonathan Director | Exercise or conversion · Restricted Stock Unit 10b5-1 | −143 | 430 | ||
| 2024-04-21 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion 10b5-1 | +644 | 206,339 | ||
| 2024-04-21 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −644 | 1,932 | ||
| 2024-04-21 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion 10b5-1 | +1,775 | 232,871 | ||
| 2024-04-21 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion · Restricted Stock Unit 10b5-1 | −1,775 | 5,324 | ||
| 2024-04-21 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion 10b5-1 | +1,145 | 73,312 | ||
| 2024-04-21 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −1,145 | 3,435 | ||
| 2024-04-20 | Sheena Jonathan Director | Exercise or conversion 10b5-1 | +190 | 321,221 | ||
| 2024-04-20 | Sheena Jonathan Director | Exercise or conversion · Restricted Stock Unit 10b5-1 | −190 | 1,332 | ||
| 2024-04-20 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion 10b5-1 | +856 | 205,695 | ||
| 2024-04-20 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −856 | 5,992 | ||
| 2024-04-20 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion 10b5-1 | +3,386 | 231,096 | ||
| 2024-04-20 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion · Restricted Stock Unit 10b5-1 | −3,386 | 23,702 | ||
| 2024-04-20 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion 10b5-1 | +1,521 | 72,167 | ||
| 2024-04-20 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −1,521 | 10,653 | ||
| 2024-04-16 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −26,511 | $90.34 | $2.4M | 171,049 |
Page 74 of 85 · 1,682 trades